|
John Patterson qualified in medicine in 1971 and obtained a Membership (now Fellowship) of the Royal College of Physicians in 1974. His career with Zeneca Pharmaceuticals spanned 20 years, starting in 1975 as Medical Adviser in the Clinical Research Department. Subsequent appointments included: Manager of Clinical Research; Medical Director, ICI Germany; Vice President of Clinical Research and Medical Affairs (USA) and, subsequently, Medical Director, ICI Pharmaceuticals. Before moving to AstraZeneca's Senior Executive Team, John held the position of Territorial Business Director, responsible for all the businesses of Zeneca Pharmaceuticals outside the USA. John had P&L responsibility for the business operations of the national entities. As Executive Vice President of Product Strategy and Licensing, John was responsible for Global Marketing for all brands, including the management of the AstraZeneca product portfolio, licensing and business development. In December 2004 John was appointed to the main Board as Executive Director responsible for Development. John has an external responsibility as Vice-Chairman of the British Pharma Group. He is a former President of the Association of the British Pharmaceutical Industry, a former Non-Executive Director of Amersham PLC and a former member of the supervisory board of the UK Medical Control Agency. | 